Pfizer’s Long Streak of Returning Capital to Investors

Pfizer has a long track record of quarterly dividends. In 2023, Pfizer has continued to return capital to shareholders with a dividend that has increased for the 14th consecutive year and a yield above the S&P 500 average.

*Data from Nasdaq Data Link, S&P 500 Dividend Yield by Month, tracking the 12-month dividend per share of 500 of the leading publicly traded companies divided by their stock price, as of June 30, 2023. Accessible here.

Join Pfizer Investor Insights

Sign up to receive important updates about Pfizer, how we’re innovating for patients and delivering value for shareholders. Email updates will also provide exciting opportunities for individual shareholders to hear from our leadership and experts.

I would like to receive information, updates, and hear from leadership regarding Pfizer Investor Insights and other investor relations initiatives in accordance with Pfizer’s Privacy Policy.